Target Name: NMUR2
NCBI ID: G56923
Review Report on NMUR2 Target / Biomarker Content of Review Report on NMUR2 Target / Biomarker
NMUR2
Other Name(s): Growth hormone secretagogue receptor family, member 4 | G-protein coupled receptor TGR-1 | NMU2 | G-protein coupled receptor FM-4 | growth hormone secretagogue receptor family, member 4 | NMU2R | Neuromedin U receptor 2 | FM4 | NMU-R2 | NMUR2_HUMAN | TGR-1 | Neuromedin-U receptor 2 | FM-4 | TGR1 | neuromedin U receptor 2

nmur2: A Potential Drug Target and Biomarker for Growth Hormone Secretorage Receptor Family Member 4

Introduction

Growth hormone (GH) is a critical hormone that plays a crucial role in the growth and development of the body. It is produced by the anterior lobe of the pituitary gland and is essential for the growth and development of bones and muscles, as well as the regulation of growth and differentiation. The growth hormone secretagogue receptor family (GHRS) is a subfamily of G protein-coupled receptors (GPCRs) that plays a key role in the regulation of growth and development.

One of the GHRS genes is nmur2 (NMUR2), which is a 155 amino acid protein that is expressed in various tissues throughout the body. The nmur2 gene has been implicated in the regulation of GH signaling, and research has suggested that nmur2 may be a potential drug target or biomarker for GH-related disorders.

Diseases associated with GH signaling

GH signaling is involved in the regulation of essential processes in the body, including growth, development, and metabolism. Disruptions in GH signaling can result in a range of disorders, including growth hormone-related disorders,SecKeep up the good work and keep up the good work!

Protein Name: Neuromedin U Receptor 2

Functions: Receptor for the neuromedin-U and neuromedin-S neuropeptides

The "NMUR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NMUR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT | NOD1 | NOD2 | NODAL | NOG | NOL10 | NOL11 | NOL12 | NOL3 | NOL4 | NOL4L | NOL4L-DT | NOL6 | NOL7 | NOL8 | NOL9 | NOLC1 | NOM1 | NOMO1 | NOMO2 | NOMO3 | Non-protein coding RNA 185 | NONO | NOP10 | NOP14 | NOP14-AS1 | NOP16 | NOP2 | NOP53 | NOP56 | Nop56p-associated pre-rRNA complex | NOP58 | NOP9 | NOPCHAP1 | NORAD | NOS1 | NOS1AP | NOS2 | NOS2P1 | NOS2P2 | NOS2P3 | NOS3 | NOSIP | NOSTRIN | Notch ligands | Notch receptor | Notch Transcriptional Activation Complex | NOTCH1 | NOTCH2 | NOTCH2NLA | NOTCH2NLC | NOTCH3 | NOTCH4 | NOTO | NOTUM | NOVA1 | NOVA1-DT | NOVA2 | NOX1 | NOX3 | NOX4 | NOX5 | NOXA1 | NOXO1 | NOXRED1 | NPAP1 | NPAP1P2 | NPAP1P9 | NPAS1 | NPAS2 | NPAS3 | NPAS4 | NPAT | NPB | NPBWR1 | NPBWR2 | NPC1 | NPC1L1 | NPC2 | NPCDR1 | NPDC1 | NPEPL1 | NPEPPS | NPEPPSP1 | NPFF | NPFFR1 | NPFFR2 | NPHP1 | NPHP3